Page 487 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 487

CHAPTER 23  ■  Myeloproliferative Neoplasms                             471







                                 CASE STUDIES (continued)
                                  CASE STUDIES (continued)





                     ■    Critical Thinking Group Discussion Questions                                                              Case Study 23. 5
                     1.  Wh  t   isor  er is suggeste   by the peripher  l bloo   f l  ?

                                                                                                                                   A 21-ye  r-ol       le   thlete visite   the sports   e  icine

                     2.  Wh  t other he    tologic  l test coul     i  erenti  te be-                                              clinic     er noting th  t his knee w  s swollen. He h     no

                           tween v  rious types o  leukocytosis?                                                                   history o  recent injuries. He reporte   h  ving  requent,

                                                                                                                                   bil  ter  l nose blee  s, blee  ing  ro   his gu  s when brush-

                                                                                                                                   ing his teeth,   n   so  e bloo   in the stool. T e   tten  ing
                         Case Study 23. 4
                                                                                                                                   orthope  ic surgeon or  ere      CBC   n   CA   sc  n o  the
                        A 58-ye  r-ol       n went to see his      ily physici  n bec  use                                         swollen knee.


                        o     3-  onth history o    izziness. On physic  l ex    in  -
                        tion, he h          ushe     ppe  r  nce. He h     spleno  eg  ly                                       ■ Laboratory Data


                        but no hep  to  eg  ly. A CBC w  s or  ere  .                                                           RBC 4.40 × 10 /L
                                                                                                                                                         12
                                                                                                                                He    tocrit 43%

                     ■    Laboratory Data                                                                                       He  oglobin 14.8 g/  L
                     RBC 5.82 × 10 /L                                                                                           WBC 12.5 × 10 /L
                                              12
                                                                                                                                                          9
                     He    tocrit 58%                                                                                           Pl  telets 955 × 10 /L
                                                                                                                                                              9
                     He  oglobin 20 g/  L


                     WBC 17.4 × 10 /L                                                                                              T e CA   sc  n o  his knee reve  le      l  rge e  usion, which
                                               9
                     Pl  telets 855 × 10 /L                                                                                        w  s bloo  y when t  ppe  .
                                                   9


                        A  ollow-up bone     rrow ex    in  tion reve  le      hyper-

                        cellul  r      rrow  with  triline  ge  hyperpl  si      n    gi  nt                                    ■ Critical Thinking Group Discussion Questions

                         eg  k  ryocytes.  T e  Prussi  n  blue  iron  st  in    e  on-                                         1. Wh  t is the prob  ble   i  gnosis, b  se   on the p  tient’s

                        str  te     bsent iron stores.                                                                                history?



                                                                                                                                2.  B  se   on the initi  l   n    ollow-up stu  ies, how   oes this
                     ■    Critical Thinking Group Discussion Questions                                                                  ise  se present  tion   i  er  ro   PRV?
                     1.  B  se   on the l  bor  tory     t  , wh  t is the suggeste     i  g-

                           nosis  or this p  tient?
                                                                                                                                3.  Is this thro  bocytosis    re  ctive thro  bosis?


                     2.  Wh  t is the   ost co    on ther  peutic   ppro  ch in this

                            isor er?
                                                                                                                                   NOTE: This is a good time to write out the answers to the

                                                                                                                                   Critical Thinking Group Discussion Questions.

                     3.  Wh  t is the   ost co    on c  use o    e  th in this   isor  er?












                                  REVIEW QUESTIONS




                      *Indicates ML   (optional) and MLS advanced content.                                                     3.  Pri    ry   yelof brosis   i  ers  ro   other types o  MPN


                      1.  MPNs   re ch  r  cterize   by   ll o  the  ollowing except                                                 in which o  the  ollowing w  ys?

                                                                                                                                               1
                            A.  clon  l   isor  ers                                                                                  A.  Ph  chro  oso  e is present.
                            B.  they     y evolve into   cute leuke  i                                                               B.  M  rrow f brosis is gre  tly incre  se  .

                            C.  initi  l incre  se o  i      ture cells                                                              C.  LAP score is incre  se  .

                            D.  incre  se   pro  uction o      ture cells                                                            D.  Pl  telet count is incre  se  .




                      2.  In CML, the tot  l leukocyte (WBC) count is                                                          4.  Which o  the  ollowing is    re    rk  ble ch  r  cteristic o

                            A.  extre  ely incre  se                                                                                 PRV co  p  re   with other types o  MPNs?

                            B.  slightly incre  se                                                                                   A.  Extre  ely incre  se   erythrocyte     ss

                            C.  extre  ely v  ri  ble                                                                                B.  Extre  ely incre  se   leukocyte count

                            D.  usu  lly nor    l                                                                                    C.  Extre  ely incre  se   pl  telet count
                                                                                                                                     D.   e  r  rop-sh  pe   erythrocytes




                                                                                                                                                                                                                    (continued)
   482   483   484   485   486   487   488   489   490   491   492